glp-1 therapy for diabetes Agonists Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1s are no longer the

Fortunately, GLP-1 agonists now offer hope and weight loss success to the thousands of people striving to lose excess fat to improve their health and overall lives

This advantage continued over time, with engaged members seeing 29.1% greater average weight loss at 12 months

Results from studies indicate that ghrelin also promotes lipid retention in adipocytes, which seems paradoxical given this hormones role as a hunger hormone, as during starvation lipids need to be released from stores and catabolised for ATP production, although it has also been argued that ghrelin protects fat stores from being utilised so that they can be used for ATP production during prolonged starvation

The evidence is there

Thats right

doi:10.1249/JSR.0b013e31825dabb8 9